MIS Spinal Surgery Instrumentation Market Size, Share and Trends Analysis | Global | 2025-2031 | MedCore

The global MIS surgery instrumentation market was valued at nearly $430 million in 2024. This is expected to increase over the forecast period at a CAGR of 5.8% to reach nearly $639 million.

The full report suite on the global market for MIS surgery instrumentation includes an aggregated analysis of all instruments used in MIS procedures.

This report includes data for 65+ countries across 7 different regions. These regions are North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.

MARKET DATA INCLUDED

• Unit Sales, Average Selling Prices, Market Size & Growth Trends
• Procedure Numbers
• Market Drivers & Limiters
• Market Forecasts Until 2031, and Historical Data to 2024
• Recent Mergers & Acquisitions
• Company Profiles and Product Portfolios
• Leading Competitors

GLOBAL MIS SPINAL SURGERY INSTRUMENTATION MARKET TRENDS

Majority of patients prefer minimally invasive procedures over traditional open fusion surgeries.

Key advantages of MIS techniques:

• Reduced muscle and tissue damage at the surgical site.
• Lower complication rates and shorter intraoperative times.

Positive clinical outcomes continue to support the shift toward MIS procedures.

Global Market Share Insights

1. 1. B. Braun

• Offers the S4(R) MIS surgery system with instruments for spondylolisthesis and fracture reduction.

2. 2. DePuy Synthes

• EXPEDIUM(R) Spine System and VIPER Spine System.
• Compatible with Brainlab and Medtronic navigation systems.
• Includes pedicle awls, probes, awl-lead taps, vertebral augmentation and general instruments.

3. 3. Globus Medical / NuVasive

• Held shares in MIS interbody fusion, MIS SI fusion, MIS pedicle screw and facet fixation.
• Strong presence in MIS instrumentation market due to innovation and bundled systems.

Research Scope Summary

Regions

• North America (Canada, United States)
• Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela)
• Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom)
• Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine)
• Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates)
• Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam)
• Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)

Base Year: 2024

Forecast Period: 2025-2031

Historical Data: 2021-2024

Quantitative Data

• Procedure Numbers
• Market Size
• Market Shares
• Market Forecasts
• Market Growth Rates
• Units Sold
• Average Selling Prices

Qualitative Data

• Market Growth Trends
• Market Limiters
• Competitive Analysis & SWOT for Top Competitors
• Mergers & Acquisitions
• Company Profiles
• Product Portfolios
• FDA Recalls
• Disruptive Technologies
• Disease Overviews

Data Sources

• Primary Interviews with Industry Leaders
• Government Physician Data
• Regulatory Data
• Hospital Private Data
• Import & Export Data
• iData Research Internal Database